+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009



Superior activity of colistin against Pseudomonas aeruginosa clinical isolates, including multidrug-resistant isolates, from multiple infection sources from 2007 to 2009



International Journal of Antimicrobial Agents 37(6): 587




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056012634

Download citation: RISBibTeXText

PMID: 21493045

DOI: 10.1016/j.ijantimicag.2011.02.011


Related references

Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. Journal of Antimicrobial ChemoTherapy 61(2): 365-370, 2008

In vitro activity of colistin against multidrug-resistant Pseudomonas aeruginosa isolates from patients in Songklanagarind Hospital, Thailand. Southeast Asian Journal of Tropical Medicine and Public Health 44(2): 273-280, 2013

Comparative assessment of antimicrobial susceptibility testing for tigecycline and colistin against Acinetobacter baumannii clinical isolates, including multidrug-resistant isolates. International Journal of Antimicrobial Agents 44(5): 396-401, 2014

Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. European Journal of Clinical Microbiology and Infectious Diseases 31(5): 695-701, 2012

Efficacy and safety of colistin for the treatment of infections caused by multidrug-resistant isolates of Pseudomonas aeruginosa sensitive to colistin in patients with haematological malignancy; a matched-pair analysis. 2007

Genomic variations between colistin-susceptible and -resistant Pseudomonas aeruginosa clinical isolates and their effects on colistin resistance. Journal of Antimicrobial ChemoTherapy 69(5): 1248-1256, 2014

Activity of AMP2041 against human and animal multidrug resistant Pseudomonas aeruginosa clinical isolates. Annals of Clinical Microbiology and Antimicrobials 16(1): 17, 2017

Antimicrobial activity of ceftolozane-tazobactam against multidrug-resistant and extensively drug-resistant Pseudomonas aeruginosa clinical isolates from a Spanish hospital. Revista Espanola de Quimioterapia 32(1): 68-72, 2019

In vitro activity of ciprofloxacin against 224 clinical isolates including resistant pseudomonas aeruginosa and staphylococcus epidermidis. Abstracts of the Annual Meeting of the American Society for Microbiology 86: 5, 1986

CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates. International Journal of Antimicrobial Agents 46(5): 568-571, 2015

In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa. Bmc Infectious Diseases 16(1): 444, 2016

In vitro combined effects of double antibacterial drugs against multidrug-resistant Pseudomonas aeruginosa isolates: comparison among combinations of colistin, arbekacin, aztreonam, rifampicin and piperacillin. Japanese Journal of Antibiotics 67(3): 167-174, 2014

New therapy from old drugs: synergistic bactericidal activity of sulfadiazine with colistin against colistin-resistant bacteria, including plasmid-mediated colistin-resistant mcr-1 isolates. International Journal of Antimicrobial Agents 51(5): 775-783, 2018

Draft Genome Sequences of Four Metallo-Beta-Lactamase-Producing Multidrug-Resistant Klebsiella pneumoniae Clinical Isolates, Including Two Colistin-Resistant Strains, from Cairo, Egypt. Microbiology Resource Announcements 8(7):, 2019

In vitro synergy of colistin combinations against colistin-resistant Acinetobacter baumannii, Pseudomonas aeruginosa, and Klebsiella pneumoniae isolates. Antimicrobial Agents and ChemoTherapy 56(9): 4856-4861, 2012